FSD Pharma (HUGE) News Today → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free HUGE Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHUGE Apr 2024 2.000 putfinance.yahoo.com - March 16 at 4:53 AMFSD Pharma Inc.: FSD Pharma Announces Debt Settlementfinanznachrichten.de - February 28 at 8:14 AMBiotech Company Develops Inebriation Remedy Beverage 'UNBUZZD'msn.com - February 26 at 7:11 PMFSD Pharma Provides Update on Proposed Dividend Distribution for Shareholders of FSD Pharma to Receive Shares of Celly Nutrition on a One for One Basisfinance.yahoo.com - November 7 at 1:42 PMFSD Pharma announces Interim Results from First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis; The Report Shows Compound to be Safe and Well Toleratedfinance.yahoo.com - September 18 at 7:41 AMFSD Pharma Selected to Present its Phase 1 Data on Lucid-MS at MSMilan 2023 – 9th Joint ECTRIMS-ACTRIMS Meeting for October 11-13, 2023finance.yahoo.com - August 15 at 8:45 AMInvestmentPitch Media Video Features FSD Pharma’s Definitive Agreement Granting Exclusive Rights for Launch of UNBUZZD, a Revolutionary Rapid Alcohol Detoxification Drinkfinance.yahoo.com - August 3 at 8:11 AMInvestmentPitch Media Video Discusses FSD Pharma’s Granting of Exclusive Rights to Revolutionary Recreational Alcohol Misuse Technology to Celly Nutritionfinance.yahoo.com - June 23 at 8:06 AMFSD Pharma Announces Agreement To Grant Exclusive Rights To Recreational Alcohol Misuse Technologymsn.com - June 20 at 8:18 PMFSD Pharma Announces Agreement to Grant Exclusive Rights to Revolutionary Recreational Alcohol Misuse Technologyfinance.yahoo.com - June 20 at 10:17 AMFSD Pharma Appoints Former Ontario Minister of Health Doctor Eric Hoskins to Board of Directorsfinance.yahoo.com - May 25 at 7:56 AMFSD Pharma Inc. (HUGE.CN)finance.yahoo.com - May 13 at 10:54 PMFSD Pharma Awarded $2.81 Million in Cost Awards From Dr. Raza Bokharifinance.yahoo.com - May 11 at 8:51 AMPromising Multiple Sclerosis Drug Candidate Advances: First Clinical Trial Dosing Completedmsn.com - May 10 at 5:48 PMFSD Pharma Completes Dosing of First Cohort in Phase I Clinical Trial of Lucid-MS, a New Drug Candidate for the Treatment of Multiple Sclerosis: Safety Review Committee Recommends Commencing Dosing of Second Cohortfinance.yahoo.com - May 10 at 7:47 AMDynamic Duo of Celsius Holdings Fame join FSD Pharma calling Medical Product under Development "Unique and Disruptive"benzinga.com - April 19 at 5:25 PMFSD Pharma Announces Plan to Spin-Out Subsidiary as Distribution to Shareholders; Shareholder Meeting Scheduled for June 29, 2023finance.yahoo.com - April 12 at 9:49 AMIIROC Trading Halt - HUGEfinance.yahoo.com - April 12 at 9:49 AMIIROC Trade Resumption - HUGEfinance.yahoo.com - April 12 at 9:49 AMFSD Pharma Presenting Two Scientific Posters on Preclinical Toxicology and Efficacy Data of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2023 Forumfinance.yahoo.com - February 21 at 8:48 AMFSD Pharma Regains Compliance with NASDAQ Continued Listing Requirementsfinance.yahoo.com - February 15 at 10:02 AMFSD Pharma receives regulatory clearance for proposed Phase 1 clinical trial of multiple sclerosis drug candidate Lucid-MSproactiveinvestors.com - February 7 at 12:06 PMFSD Pharma submits clinical trial application for its multiple sclerosis treatment candidate Lucid-MSproactiveinvestors.com - January 17 at 1:35 PMFSD Pharma submits its phase-1 Clinical Trial Application for Lucid-MS (Lucid-21-302) for first-in-human safety and tolerability investigationfinance.yahoo.com - January 17 at 8:35 AMTesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On Mondaymsn.com - January 9 at 3:33 PMFSD Pharma incorporates new subsidiary to capitalize on drug development incentives in Australiaproactiveinvestors.com - January 9 at 10:32 AMFSD Pharma Inc Incorporates New Subsidiary to Capitalize on Drug Development Incentives in Australiafinancialpost.com - January 9 at 8:37 AMFSD Pharma to Attend 41st Annual J.P. Morgan Healthcare Conference 2023finance.yahoo.com - January 6 at 8:37 AMFDA and Health Canada Clear IND for FSD Pharma to Proceed with Phase 2 Trial of FSD201 for Nociplastic Pain Associated with Idiopathic Mast Cell Activation Syndromefinance.yahoo.com - September 6 at 10:25 AMFSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets clearanceproactiveinvestors.com - June 1 at 5:56 PMFSD Pharma Announces Dismissal of Derivative Complaintfinance.yahoo.com - May 6 at 2:17 PMFSD Pharma engages Tekkfund to help with business development strategiesseekingalpha.com - May 2 at 7:18 AMFSD Pharma adds two new faces to its advisory boardproactiveinvestors.com.au - April 21 at 1:39 PMFSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John McGraw to Advisory Boardfinance.yahoo.com - April 21 at 8:39 AMFSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokharifinance.yahoo.com - April 8 at 8:55 AMFSD Pharma Announces Executive Informational Overview Report Produced by Crystal Research Associates LLCnz.finance.yahoo.com - March 15 at 3:47 AMStocks in play: FSD Pharma Inctheglobeandmail.com - February 25 at 12:53 PMFSD Pharma Inc. Class B Subordinate Voting Shares (HUGE)nasdaq.com - January 18 at 8:31 PMVectoIQ Acquisition Corp. II VTIQstockhouse.com - January 6 at 8:22 AMXpresSpa Group Inc. XSPAstockhouse.com - January 1 at 2:06 PMPinterest Inc. Class A PINSstockhouse.com - January 1 at 2:06 PMRoyal Mail Plc ADR ROYMYstockhouse.com - January 1 at 9:06 AMA “HUGE” Investment Opportunity in Neurodegenerative and Mental Health Treatmentsstockhouse.com - December 22 at 6:10 PMHarvard Bioscience Inc. HBIOstockhouse.com - December 15 at 5:58 AMAGNC Investment Corp. AGNCstockhouse.com - December 14 at 5:35 PMAlibaba Health Information Technology Limited ADR ALBBYstockhouse.com - December 10 at 12:00 PMCoca-Cola Consolidated Inc COKEBstockhouse.com - December 10 at 7:00 AMExtreme Motorsports of California, Inc. EMOCstockhouse.com - December 8 at 7:39 AMA. Soriano Corporation SRIOFstockhouse.com - December 8 at 7:39 AMAirbus SE ADR - Level I EADSYstockhouse.com - December 7 at 5:41 AM Get FSD Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HUGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… HUGE Media Mentions By Week HUGE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HUGE News Sentiment▼0.000.59▲Average Computer and Technology News Sentiment HUGE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HUGE Articles This Week▼00▲HUGE Articles Average Week Get FSD Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HUGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: HOC News OEE News LTV News ID News ISD News ROI News ALY News ART News INX News IQ News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CNSX:HUGE) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FSD Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.